Warticon Solution

Warticon is a topical treatment for external genital warts — small, soft growths on the skin of the genital or perianal area caused by HPV infection. It contains podophyllotoxin, a plant-derived compound originally isolated from the May apple plant, and it's used at home to clear visible warts over a period of one to four weeks. It's licensed specifically for external warts on the skin of the penis, vulva, and around the anus. It's not used inside the vagina, on the cervix, inside the urethra, or inside the rectum — those areas need clinic-based treatments instead, because the skin is much more delicate and the active ingredient can be too irritating.

This is genuinely interesting if you understand the basics of how cells divide. Most living cells, including the cells in a wart, multiply by going through a tightly choreographed dance called mitosis, in which the cell duplicates its DNA and pulls the two copies apart along a scaffold of protein cables called microtubules. Podophyllotoxin works by binding to the protein (tubulin) that those cables are made of, jamming the scaffold so it can't form properly. Cells that try to divide while the scaffold is jammed get stuck in mid-division and die. Because wart tissue is dividing rapidly compared to surrounding healthy skin, it's especially vulnerable to this effect. Over several treatment cycles, the wart tissue dies off layer by layer until the wart is gone. The virus itself can still linger in the surrounding skin, which is why warts sometimes come back — but Warticon is highly effective at clearing what's visibly there.

The active ingredient is the same; the formulation and the way you apply it differ. Warticon cream (0.15%) is a soft, white cream applied with a fingertip — most women find this easier for warts on the vulva, where the surfaces are more contoured. Warticon solution (0.5%) is a clear liquid applied with the small applicator loop or stick provided in the pack — most men find this easier for warts on the penis, where the smaller surface area benefits from precise application. Both forms achieve similar clearance rates when used properly, so the choice usually comes down to where the warts are and which feels more practical to apply.

The standard regimen is twice daily for three consecutive days, followed by four days off — a pattern that makes up one "cycle" of treatment. You apply a small amount directly to the wart, taking care to avoid the surrounding healthy skin where possible, allow it to dry for a few minutes before dressing, and wash your hands thoroughly afterwards. The four-day rest period that follows isn't padding; it's an essential part of the regimen, because it gives the surrounding skin time to recover from the irritation that podophyllotoxin inevitably causes. After four days off, you start the next cycle. Some patients find it helpful to mark the cycle on a calendar or set a phone reminder, because the on-off rhythm is easy to lose track of.

Up to four cycles — a maximum of four weeks of treatment. Many people clear their warts in two or three cycles, but if warts remain after four cycles, you should stop and see a clinician rather than continuing. There are two reasons for this limit. First, beyond four weeks, the risk of significant skin damage and ulceration rises without a corresponding rise in benefit. Second, persistent warts after four cycles often respond better to a different treatment approach — for example, imiquimod cream (Aldara), cryotherapy (freezing in clinic), or minor surgical removal — and continuing the same approach indefinitely isn't usually the answer.

Many people notice the warts beginning to shrink, change colour, or develop a slightly inflamed appearance within the first cycle. The treated tissue often becomes red, sore, or develops shallow ulcers as the wart cells die and slough off — this isn't a side effect to be worried about so much as a sign the medicine is working. Full clearance, where it's going to happen, typically occurs within two to four cycles. If a wart hasn't started to respond at all by the end of the second cycle, it's worth a clinical review rather than persisting blindly.

Local skin reactions are expected rather than unusual. The most commonly reported effects are burning, stinging, redness, itching, soreness, and shallow ulceration of the treated area. Most people experience some of these, particularly during the active three-day phase of each cycle, and they usually settle during the four-day rest. More severe reactions — large painful ulcers, bleeding, or significant swelling — mean it's time to stop and seek advice, because the medicine may need to be paused or changed. Systemic side effects (effects on the rest of the body) are very rare with podophyllotoxin used as directed on small areas of skin, but can occur if it's applied to large surface areas or to broken or inflamed skin, which is why following the application instructions matters more than it might seem.

Podophyllotoxin is teratogenic — meaning it can interfere with the development of an unborn baby. Animal studies have shown effects on fetal development at sufficient exposure levels, and although the amount absorbed from a small skin application is low, the consequences of any exposure during early pregnancy are serious enough that podophyllotoxin is firmly contraindicated in pregnancy. If you're pregnant or might be, and you have visible genital warts, the safe approach is a clinic visit rather than self-treatment — cryotherapy and trichloroacetic acid are commonly used in pregnancy as alternatives. The same caution applies to breastfeeding, where it's also avoided. If you're trying to conceive, mention this to your prescriber so the right treatment can be chosen.

It's strongly advised to avoid penetrative sex during treatment, for several reasons. First, the medicine itself can transfer to a partner's skin and cause irritation. Second, sex can dislodge the cream or solution before it has had time to work. Third, friction during sex can worsen the soreness and ulceration that often develops at treated sites. Fourth, although the wart-causing strains of HPV are usually not the cancer-causing strains, the virus is still transmissible and warts are most contagious when they're actively present. Most clinicians suggest avoiding sex until at least the warts have cleared and the skin has fully healed, which is often a couple of weeks beyond the last treatment.

This is one of the hardest questions emotionally, and there isn't a single right answer — but a few honest points help. HPV is extremely common, and by the time genital warts appear, the virus has often been present for weeks, months, or even years, which makes it very difficult to know when transmission occurred or who passed it to whom. Partner notification is therefore less about blame and more about giving partners the chance to look out for symptoms themselves and to make informed decisions about safer sex during your treatment. Current sexual partners should generally be told, because they may also have warts (sometimes silent ones, in less visible places) and may benefit from review. Sexual health clinics can help with conversations like this and can even, in some cases, contact partners on your behalf. Past partners are usually not contacted in HPV cases because of the long and uncertain incubation period.

Sometimes, yes — and it's important to understand why, because the answer is reassuring rather than alarming. Warticon clears the visible wart tissue extremely well, but it doesn't eliminate the underlying HPV infection in the surrounding skin. In around 20 to 40 per cent of people, new warts appear within a few months of clearance, usually because viral particles in nearby skin go on to form new lesions. The good news is that recurrences usually respond well to a second course of Warticon, that the immune system gradually controls the virus over time (most people clear HPV within one to two years even without treatment), and that recurrences become less frequent as the immune response strengthens.

If warts haven't started to shrink after two cycles, or if they're still present after the maximum four cycles, a different treatment approach is usually needed. The most common alternatives are imiquimod cream (Aldara), which works very differently — by stimulating the local immune system to attack the virus rather than directly killing wart cells; cryotherapy, where a clinician freezes the warts with liquid nitrogen; trichloroacetic acid, a chemical applied in clinic; and minor surgical or electrosurgical removal for resistant or large warts. Sometimes a combination approach works best — for example, treating with Warticon first to reduce wart bulk, then using imiquimod or cryotherapy to deal with what remains. A sexual health clinic can review your situation and choose the next step rather than you having to navigate this alone.

The two medicines are completely different in mechanism, even though both treat genital warts. Warticon is cytotoxic — it directly kills wart cells by stopping them from dividing. Aldara is an immunomodulator — it doesn't kill wart cells directly, but it stimulates the local immune system to recognise and attack HPV-infected cells. The practical differences are: Warticon is faster (typically clearing warts in one to four weeks) but has a higher recurrence rate; Aldara is slower (typically taking up to 16 weeks) but tends to have a lower recurrence rate, possibly because the immune response it generates also helps clear residual virus in the surrounding skin. Aldara is applied three nights a week and is a cream rather than a precise application, which makes it better for larger or scattered warts. Warticon's twice-daily three-day cycles are more intensive but more targeted. Many prescribers will discuss both and choose based on the wart pattern, the patient's lifestyle, and previous treatment history.

HPV vaccination doesn't treat existing infection, so the vaccine won't make current warts disappear. However, it does protect against the strains of HPV you haven't yet encountered — including the wart-causing types 6 and 11 (covered by Gardasil 9, the vaccine used in the UK NHS programme) and the cancer-causing high-risk types 16, 18, 31, 33, 45, 52, and 58. If you've had genital warts and haven't been vaccinated, vaccination may still be worthwhile because it can reduce the chance of future infection with strains you haven't yet caught and may reduce recurrence. The NHS programme offers vaccination free to children of both sexes around age 12 to 13, with a catch-up programme up to age 25 for those who missed it. Outside that age range, vaccination is available privately and is increasingly being considered for adults who have had wart episodes.

A few situations call for in-person review rather than continuing alone. Any wart that is unusually large, bleeding, painful, pigmented, ulcerated, or rapidly changing in appearance needs assessment, because in rare cases what looks like a wart can be something else (including, very rarely, a skin cancer). Warts inside the vagina, on the cervix, inside the urethra, or inside the rectum need clinic-based treatments and aren't suitable for Warticon. Pregnancy or trying to conceive means Warticon is off the table and a different option is needed. Recurrent warts despite multiple courses, warts in someone whose immune system is suppressed (for example by HIV or immunosuppressant medications), and any concern about other sexually transmitted infections all warrant a sexual health clinic visit — which, on the NHS, is free, confidential, and used to seeing exactly these situations without judgement.